February 19, 2026 11:00 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
PM Modi warns ‘AI must not control humans’ as India unveils bold tech vision at AI Impact Summit 2026 | Former South Korean President Yoon Suk Yeol sentenced to life over failed martial law bid | Tata Group joins hands with OpenAI in massive AI push to transform India and global industries | Epstein Files row: Bill Gates to skip keynote address at AI Summit 2026 | AI Impact Summit: Google launches game-changing America-India Connect plan with $15 billion backing | AI takes centre stage as Modi meets Google CEO Sundar Pichai in Delhi | G7 Spotlight: Emmanuel Macron invites Narendra Modi for 2026 Summit | AI Summit embarrassment! Galgotias University asked to vacate stall after ‘own robot’ exposed as China’s Unitree Go2 | Actor Rajpal Yadav granted interim bail in ₹9-crore cheque bounce case | Learn AI or become redundant: Microsoft India President issues stark message
Vaccine dry run
Image Credit: Unsplash

Ahead of Covid-19 vaccine rollout, second dry run to be held on Friday

| @indiablooms | Jan 07, 2021, at 04:18 am

New Delhi/IBNS: A second dry run for the Covid-19 vaccination will be held in all states on Friday, media reports said.

The first large scale dry-run was conducted in all states and UTs on Jan 2 with an objective to test operational feasibility of the use of CO-WIN app, assess the linkage between planning and  implementation as well as to identify challenges before actual implementation.

The second exercise is an attempt to check the best way to vaccinate people against Covid-19 and find out loopholes in logistics and training.

The day-long drive on Friday will again test the operational feasibility of CoWIN application in a field environment.

Short for Covid Vaccine Intelligence Network, CoWIN is a digital platform to roll out and scale up the vaccination drive.

The Centre on Tuesday informed that Covid-19 vaccines will be ready for rollout in 10 days from the emergency use authorisation date based on feedback from the dry run.

Two Covid-19 vaccine candidates-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-on Sunday received the approval of the Drugs Controller General of India (DCGI) for emergency use in India.

The announcement by the Centre came as a relief amid growing fears over the spread of the mutant strain of coronavirus, that was first detected in the UK and is up to 70 per cent more infectious.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.